Literature DB >> 26062001

Thrombospondin-1 and Pathogenesis of Age-Related Macular Degeneration.

Michael Housset1,2,3, Florian Sennlaub1,2,3,4.   

Abstract

The cardinal features of age-related macular degeneration (AMD) are the accumulation of subretinal debris, subretinal inflammation, neovascularization, and degeneration of the photoreceptors and retinal pigment epithelium (RPE). Thrombospondin-1 (TSP-1) is a major matricellular protein that is physiologically expressed in the RPE and choroid, but severely diminished in eyes with AMD. TSP-1 plays an important role in phagocytosis, potently inhibits neovascularization, and mediates immune suppression and immune privilege. The lack of TSP-1 could have a central role in the pathogenesis of AMD as it is implicated in the major pathways that seem to be deficient in the disease. We here give an overview of the major functions of TSP-1 and how it could intervene in AMD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062001     DOI: 10.1089/jop.2015.0023

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  3 in total

Review 1.  New insights into mononuclear phagocyte biology from the visual system.

Authors:  Nancy J Reyes; Emily G O'Koren; Daniel R Saban
Journal:  Nat Rev Immunol       Date:  2017-03-27       Impact factor: 53.106

2.  FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration.

Authors:  Nadine Reichhart; Gerhild Wildner; Olaf Strauß; Ahmad Samir Alfaar; Lucas Stürzbecher; Maria Diedrichs-Möhring; Marion Lam; Christophe Roubeix; Julia Ritter; Kathrin Schumann; Balasubramaniam Annamalai; Inga-Marie Pompös; Bärbel Rohrer; Florian Sennlaub
Journal:  J Neuroinflammation       Date:  2022-10-22       Impact factor: 9.587

3.  IGFBP‑rP1‑silencing promotes hypoxia‑induced angiogenic potential of choroidal endothelial cells via the RAF/MEK/ERK signaling pathway.

Authors:  Shuting Zhu; Hong Wang; Zhihua Zhang; Mingming Ma; Zhi Zheng; Xun Xu; Tao Sun
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.